Project Grant R24OD037800
Award Date
5/1/25
Completion Date
2/28/29
Dollars Obligated
$845K
Funding Federal Agency
Office of the Director
Awarding Federal Agency
Aggregate Financial Assistance Data
Federal Grant Program
93.351
Assistance Type
Project Grant
Place of Performance
New York, NY 10016, USA
Similar Awards
This Project Grant award from the National Institutes of Health (NIH) under the Research Infrastructure Programs (CFDA 93.351) provides $881,450.00 to the University of Massachusetts Medical School (UMass Medical) to develop novel humanized mouse models for engrafting human tissue-specific macrophage populations. The goal is to generate NSG mouse strains that are deficient in mouse tissue resident macrophages and express human cytokines to promote the development of human myeloid cells,...
This federal Project Grant award from the National Institutes of Health (NIH) under the Research Infrastructure Programs (CFDA 93.351) will fund the development of two novel mouse models at Cornell University. The $235,500 award, effective September 1, 2024 through June 30, 2026, will support the creation of a "unilateral mosaic" mouse model to study asymmetric disease pathology and a genetically-engineered mouse with a cell-tracing system to map cellular interactions in vivo. The...
This Project Grant award from the National Institutes of Health (NIH), under the Research Infrastructure Programs (CFDA 93.351), provides $775,888 to the La Jolla Institute for Immunology (LJI) to create and validate a modular CRISPR-ready HLA transgenic mouse platform. The goal is to develop a versatile mouse model that can be customized with different HLA class I and II alleles to study T cell responses across a broad range of diseases, from infectious diseases to cancer, autoimmune disorders,...
This federal Project Grant award from the National Institutes of Health (NIH), under the Research Infrastructure Programs (CFDA 93.351), supports the development of a novel mouse model system for targeted trimming of disease susceptibility loci. The goal is to streamline the identification of causative genes within large susceptibility loci, enabling more efficient advancement of disease mechanism studies and therapeutic development. The $261,017 award, with a project period from May 1, 2025...
This Project Grant award from the National Institutes of Health (NIH) Office of the Director (CFDA 93.351 - Research Infrastructure Programs) provides $240,039 to Baylor College of Medicine to develop a novel mouse model for detecting genome editing events, particularly those generated by CRISPR/Cas9 technology. The project aims to design and test a more sensitive "single-hit" strategy for detecting CRISPR/Cas9 editing in the existing AI9 mouse model. This will involve fusing the Cre...
This Project Grant award from the National Institute of General Medical Sciences (CFDA 93.859 Biomedical Research and Research Training program) provides $330,025 to the University of Nebraska Medical Center (UNMC) to develop prototype mouse models for mRNA delivery and technology development. The objective is to explore the potential of the newly discovered SEND (Selective Endogenous Encapsidation for Cellular Delivery) cellular mRNA transfer process as a gene therapy delivery system. The award...
This $1,737,000 Project Grant awarded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) supports the development of innovative single-cell genomics technologies for joint analysis of regulatory dynamics and transcriptional states. Key objectives include: Developing multiomics tools to measure rates of epigenomic changes (DNA methylation, demethylation, oxidative damage, DNA repair) and relate these to...
This federal Project Grant award from the National Institutes of Health (NIH) under the Research Infrastructure Programs (CFDA 93.351) provides $265,500 to the Jackson Laboratory to rapidly develop mouse resource strains through the application of prime editing technology. The key objectives are to leverage prime editing, a novel CRISPR-based gene editing approach, to efficiently modify and functionally tag thousands of mouse genes without the need for labor-intensive microinjection methods. The...
The National Institutes of Health (NIH) awarded a $293,550 Project Grant under the Research Infrastructure Programs (CFDA 93.351) to Seattle Children's Hospital, doing business as Seattle Children's Research Institute, to develop multiple genetic tools including inbred lines, embryonic stem cells, and whole animal transgenesis. The goal is to establish the Acomys mouse as an experimentally and genetically tractable model for studying mammalian non-fibrotic regenerative healing and healthy aging....
This Project Grant award, with ID R24OD038108, was provided by the National Institutes of Health (NIH) under the Research Infrastructure Programs (CFDA 93.351). The total funding amount is $718,404 and the award period is from April 15, 2025 to March 31, 2029. The goal of this award is to generate a new outbred mouse population, the Wild Mouse Diversity Panel (WMDP), derived from novel wild-derived inbred strains of the Mus musculus domesticus subspecies. This new mouse resource is intended to...